TRANSCENTA-B: Next Day Disclosure Returns
May 3 21:23
TRANSCENTA-B: Next Day Disclosure Returns
May 2 18:14
TRANSCENTA-B: Next Day Disclosure Returns
Apr 30 18:53
TRANSCENTA-B: LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
Apr 30 16:54
TRANSCENTA-B: Next Day Disclosure Returns
Apr 30 16:43
TRANSCENTA-B: APPOINTMENT OF A MEMBER OF NOMINATION COMMITTEE AND RESIGNATION OF EXECUTIVE DIRECTOR
Apr 30 16:30
TRANSCENTA-B: Next Day Disclosure Returns
Apr 26 19:12
TRANSCENTA-B: Next Day Disclosure Returns
Apr 25 18:58
TRANSCENTA-B: Next Day Disclosure Returns
Apr 24 19:04
TRANSCENTA-B: Next Day Disclosure Returns
Apr 23 19:04
TRANSCENTA-B: Next Day Disclosure Returns
Apr 22 19:37
TRANSCENTA-B: Next Day Disclosure Returns
Apr 18 19:42
TRANSCENTA-B: NOTIFICATION LETTER AND REPLY FORM TO REGISTERED HOLDERS
Apr 18 16:34
TRANSCENTA-B: 2023 Environmental, Social and Governance Report
Apr 18 16:33
TRANSCENTA-B: NOTIFICATION LETTER AND REQUEST FORM TO NON-REGISTERED HOLDERS
Apr 18 16:32
TRANSCENTA-B: 2023 ANNUAL REPORT
Apr 18 16:30
TRANSCENTA-B: Next Day Disclosure Returns
Apr 17 18:45
TRANSCENTA-B: Next Day Disclosure Returns
Apr 16 19:51
TRANSCENTA-B: VOLUNTARY ANNOUNCEMENT-BUSINESS UPDATE ON COLLABORATION WITH AGILENT TO DEVELOP A CLAUDIN18.2 COMPANION DIAGNOSTIC TO SUPPORT OSEMITAMAB (TST001) GLOBAL PHASE III TRIAL
Apr 9 06:39
TRANSCENTA-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024
Apr 5 16:32
No Data
No Data